Status
Conditions
About
The goal of this study is to identify and characterize novel non-coding and splicing variants that may contribute to genetic disorders. We will particularly focus on patients with a diagnosed genetic disorder that has inconclusive genetic findings.
Full description
To perform this study, we will use patient DNA and RNA that is isolated from blood samples. DNA will be sequenced (targeted capture and/or whole genome DNA sequencing (WGS)) to identify any non-coding single nucleotide variants (SNVs), smaller insertions/deletions (indels), or larger structural variants (SVs). RNA will be sequenced (RNA-seq) to identify genes that are expressed in a differential and/or allele-specific manner, which may indicate a functional non-coding or splicing variant. We will test the function of non-coding variants using high-throughput reporter assays and CRISPR based methodologies.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Inclusion criteria:
Subjects will have one or more of the following:
Exclusion Criteria: There are no exclusion criteria for this study.
Loading...
Central trial contact
Erica Nading, MS, CGC
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal